Internalizing RGD, a great motif for targeted peptide and protein delivery: a review article
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
https://link.springer.com/content/pdf/10.1007/s13346-022-01116-7.pdf
Reference68 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Can J Clin. 2021. https://doi.org/10.3322/caac.21660
2. Shafiee F, Aucoin MG, Jahanian-Najafabadi A. Targeted diphtheria toxin-based therapy: a review article. Frontiers Microbiol. 2019. https://doi.org/10.3389/fmicb.2019.02340.
3. Das M, Mohanty C, Sahoo SK. Ligand-based targeted therapy for cancer tissue. Exp Opin Drug Del. 2009. https://doi.org/10.1517/17425240902780166.
4. Scott AM, Allison JP, Wolchok JD. Monoclonal antibodies in cancer therapy. Can Immun Arch. 2012. https://doi.org/10.3390/antib9030034.
5. Shafiee F, Minaiyan G, Moazen F, Jahanian-Najafabadi A. Recombinant production and intein-mediated purification of an antimicrobial peptide, BR2. Int J Pep Res Ther. 2017. https://doi.org/10.1007/s10989-017-9583-7.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic;ACS Pharmacology & Translational Science;2024-01-24
2. Dual targeting of DR5 and VEGFR2 molecular pathways by multivalent fusion protein significantly suppresses tumor growth and angiogenesis;International Journal of Biological Macromolecules;2024-01
3. RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions;Cancer Medicine;2024-01
4. Cancer therapy with iRGD as a tumor-penetrating peptide;Bulletin du Cancer;2023-12
5. Molecular View on the iRGD Peptide Binding Mechanism: Implications for Integrin Activity and Selectivity Profiles;Journal of Chemical Information and Modeling;2023-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3